Literature DB >> 11405974

Interventions for treating constipation in pregnancy.

D J Jewell1, G Young.   

Abstract

BACKGROUND: Constipation is a common problem in late pregnancy. Circulating progesterone may be the cause of slower gastrointestinal movement in mid and late pregnancy.
OBJECTIVES: The objective of this review was to assess the effects of different methods for treating constipation in pregnancy. SEARCH STRATEGY: We searched the Cochrane Pregnancy and Childbirth Group trials register, the Cochrane Controlled Trials Register and MEDLINE. Date of last search: January 2001. SELECTION CRITERIA: Randomised trials of any treatment for constipation in pregnancy. DATA COLLECTION AND ANALYSIS: Trial quality assessments and data extraction were done independently by two reviewers. MAIN
RESULTS: Two suitable trials were identified. Fibre supplements increased the frequency of defecation (odds ratio 0.18, 95% confidence interval 0.05 to 0.67), and lead to softer stools. Stimulant laxatives are more effective than bulk-forming laxatives (odds ratio 0.30, 95% confidence interval 0.14 to 0.61), but may cause more side effects. REVIEWER'S
CONCLUSIONS: Dietary supplements of fibre in the form of bran or wheat fibre are likely to help women experiencing constipation in pregnancy. If the problem fails to resolve, stimulant laxatives are likely to prove more effective.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11405974     DOI: 10.1002/14651858.CD001142

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  9 in total

1.  Defecatory symptoms during and after the first pregnancy: prevalences and associated factors.

Authors:  H Jorien van Brummen; Hein W Bruinse; Geerte van de Pol; A Peter M Heintz; C Huub van der Vaart
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-08-03

Review 2.  Treating constipation during pregnancy.

Authors:  Magan Trottier; Aida Erebara; Pina Bozzo
Journal:  Can Fam Physician       Date:  2012-08       Impact factor: 3.275

Review 3.  Gut microbiota in gastrointestinal diseases during pregnancy.

Authors:  Zhong-Zhen Liu; Jing-Hua Sun; Wen-Jing Wang
Journal:  World J Clin Cases       Date:  2022-04-06       Impact factor: 1.534

Review 4.  Wheat bran: its composition and benefits to health, a European perspective.

Authors:  Leo Stevenson; Frankie Phillips; Kathryn O'Sullivan; Jenny Walton
Journal:  Int J Food Sci Nutr       Date:  2012-06-20       Impact factor: 3.833

5.  Effects of Crude Oil/Dispersant Mixture and Dispersant Components on PPARγ Activity in Vitro and in Vivo: Identification of Dioctyl Sodium Sulfosuccinate (DOSS; CAS #577-11-7) as a Probable Obesogen.

Authors:  Alexis M Temkin; Robert R Bowers; Margaret E Magaletta; Steven Holshouser; Adriana Maggi; Paolo Ciana; Louis J Guillette; John A Bowden; John R Kucklick; John E Baatz; Demetri D Spyropoulos
Journal:  Environ Health Perspect       Date:  2015-07-02       Impact factor: 9.031

6.  Increased adiposity, inflammation, metabolic disruption and dyslipidemia in adult male offspring of DOSS treated C57BL/6 dams.

Authors:  Alexis M Temkin; Robert R Bowers; Candice Z Ulmer; Kayla Penta; John A Bowden; Jennifer Nyland; John E Baatz; Demetri D Spyropoulos
Journal:  Sci Rep       Date:  2019-02-06       Impact factor: 4.379

7.  Comparison of two questionnaires to diagnose obstructive defecation syndrome during pregnancy and post-natally.

Authors:  Joanne Sentance; Katie Stocking; Richard J Edmondson; Rohna Kearney
Journal:  Int Urogynecol J       Date:  2022-03-10       Impact factor: 1.932

Review 8.  Interventions for treating constipation in pregnancy.

Authors:  Phassawan Rungsiprakarn; Malinee Laopaiboon; Ussanee S Sangkomkamhang; Pisake Lumbiganon; Jeremy J Pratt
Journal:  Cochrane Database Syst Rev       Date:  2015-09-04

Review 9.  A review of the methodological features of systematic reviews in maternal medicine.

Authors:  Lumaan Sheikh; Shelley Johnston; Shakila Thangaratinam; Mark D Kilby; Khalid S Khan
Journal:  BMC Med       Date:  2007-05-24       Impact factor: 8.775

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.